Sangamo Therapeutics
SGMO
$0.49
Share price
-5.36%
Change (1 day)
-70.12%
Change (1 year)
Sangamo Therapeutics (SGMO) - Total debt
Total debt on the balance sheet as of December 2023 : $38.1 M
According to Sangamo Therapeutics 's latest financial reports the company's total debt is $38.1 M. A company’s total debt is the sum of all current and non-current debts.
Sangamo Therapeutics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $38.1 M | -11.61% |
| 2022-12-31 | $43.1 M | -10.34% |
| 2021-12-31 | $48.08 M | 14.24% |
| 2020-12-31 | $42.08 M | -5.22% |
| 2019-12-31 | $44.4 M | 60.37% |
| 2018-12-31 | $27.68 M | 11.93% |
| 2017-12-31 | $24.73 M | 527.07% |
| 2016-12-31 | $3.94 M | |
| 2015-12-31 | $N/A | |
| 2001-12-31 | $0.28 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 76,878.79% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 169,470.12% | 🇺🇸 USA |
 Biogen BIIB | $7.33 B | 19,158.35% | 🇺🇸 USA |
 Dow DOW | $16.44 B | 43,063.45% | 🇺🇸 USA |
 Gilead Sciences GILD | $24.98 B | 65,475.79% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 91,898.22% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $1.30 B | 3,325.86% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 2,775.68% | 🇺🇸 USA |